About BioNTech Australia

BioNTech Australia was established in December 2023 to build a research and development (R&D) laboratory and clinical GMP mRNA manufacturing facility at La Trobe University’s Bundoora campus in Melbourne. An Innovation Centre has been established in Melbourne that leverages BioNTech’s mRNA expertise to support the Australasian ecosystem in translating research from concept to clinical applications. Additionally, BioNTech’s clinical trial footprint in Australia is progressing multiple investigational cancer therapies for indications with high unmet medical need. The Victorian Government through mRNA Victoria is a strategic partner of BioNTech advancing innovative mRNA research and development within the Australasian ecosystem.  

Our vision and mission

We are dedicated to translating science into survival by harnessing the potential of the human immune system to improve the health of people worldwide through innovative immunotherapies and vaccines targeting cancer and infectious diseases.

Learn more

Our history

Explore BioNTech’s journey from a small startup to a global biotechnology company dedicated to ushering in a new era of medicine with combination therapies based on novel therapeutic approaches.

Learn more

Annual report 

Reflecting on the achievements of 2025, our guiding motto for this year’s annual report, “Momentum”, encapsulates the progress that defined the past year for us: We achieved key milestones that strengthened our position in oncology, validated our approaches with encouraging data, and set the stage for significant progress in 2026. Read more about those milestones in our report.

Download the 2025 annual report

18 MB / PDF

Explore more about BioNTech